GH Research's inhaled psychedelic therapy GH001 has shown promise in a mid-stage trial in treatment-resistant depression (TRD), sending its shares soaring and prompting a $150 million offering to ...

Poppy Playtime has a big cast of characters across its first four chapters, and we're here to break down their motivations, past, and lore so you can catch up on the wider story. On this page, we'll ...

During your journey through the halls of Playtime Co in Poppy Playtime, you'll soon come to realize there's a puppetmaster pulling the strings somewhere deeper in the factory. This puppetmaster is an ...

GH Research PLC, together with its subsidiary, a clinical-stage biopharmaceutical company, engages in developing treatments for depression in the United States. Its lead product candidate is GH001, an ...